Works matching AU Giugliano, Robert P


Results: 120
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16

    Association of glomerular filtration rate on presentation with subsequent mortality in non-ST-segment elevation acute coronary syndrome; observations in 13307 patients in five TIMI trials.

    Published in:
    European Heart Journal, 2004, v. 25, n. 22, p. 1998, doi. 10.1016/j.ehj.2004.08.016
    By:
    • Gibson, C. Michael;
    • Dumaine, Raphaelle L.;
    • Gelfand, Eli V.;
    • Murphy, Sabina A.;
    • Morrow, David A.;
    • Wiviott, Stephen D.;
    • Giugliano, Robert P.;
    • Cannon, Christopher P.;
    • Antman, Elliott M.;
    • Braunwald, Eugene
    Publication type:
    Article
    17
    18
    19

    Acute Coronary Syndromes: From the Emergency Department to the Catheterization Laboratory-Integrating Evidence from Recent ACS/NSTEMI Trials into Clinical Practice: An Evidence-Based Review of Recent Clinical Trial Results and Report on a Roundtable Discussion

    Published in:
    Journal of Interventional Cardiology, 2011, v. 24, n. 2, p. 119, doi. 10.1111/j.1540-8183.2010.00607.x
    By:
    • Giugliano, Robert P.;
    • Pollack, Jr., Charles V.;
    • Brogan, Jr., Gerard X.;
    • Cohen, Marc;
    • Diercks, Deborah B.;
    • Grines, Cindy L.;
    • Henry, Timothy D.;
    • Kleiman, Neal S.
    Publication type:
    Article
    20

    The Use of Oral Beta-Blockers and Clinical Outcomes in Patients with Non-ST-Segment Elevation Acute Coronary Syndromes: a Long-Term Follow-Up Study.

    Published in:
    Cardiovascular Drugs & Therapy, 2018, v. 32, n. 5, p. 435, doi. 10.1007/s10557-018-6818-6
    By:
    • Nicolau, Jose C.;
    • Furtado, Remo H. M.;
    • Baracioli, Luciano M.;
    • Lara, Livia M.;
    • Dalçóquio, Talia F.;
    • Scanavini Junior, Marco A.;
    • Pereira, César A. C.;
    • Lima, Viviane M.;
    • Gonçalves, Talita M.;
    • Colodetti, Raíza;
    • Ferrari, Aline G.;
    • Lopes, Renato D.;
    • Giugliano, Robert P.
    Publication type:
    Article
    21

    Relationship of diabetes, heart failure, and N‐terminal pro‐B‐type natriuretic peptide with cardiovascular outcomes in patients with atrial fibrillation.

    Published in:
    ESC Heart Failure, 2022, v. 9, n. 4, p. 2367, doi. 10.1002/ehf2.13930
    By:
    • Hofer, Felix;
    • Pailer, Ulrike;
    • Sulzgruber, Patrick;
    • Gerges, Christian;
    • Winter, Max‐Paul;
    • Giugliano, Robert P.;
    • Gottsauner‐Wolf, Michael;
    • Hülsmann, Martin;
    • Kazem, Niema;
    • Koller, Lorenz;
    • Schönbauer, Robert;
    • Niessner, Alexander;
    • Hengstenberg, Christian;
    • Zelniker, Thomas A.
    Publication type:
    Article
    22
    23
    24

    Design and rationale of the EBBINGHAUS trial: A phase 3, double-blind, placebo-controlled, multicenter study to assess the effect of evolocumab on cognitive function in patients with clinically evident cardiovascular disease and receiving statin background lipid-lowering therapy-A cognitive study of patients enrolled in the FOURIER trial

    Published in:
    Clinical Cardiology, 2017, v. 40, n. 2, p. 59, doi. 10.1002/clc.22678
    By:
    • Giugliano, Robert P.;
    • Mach, Francois;
    • Zavitz, Kenton;
    • Kurtz, Christopher;
    • Schneider, Jingjing;
    • Wang, Huei;
    • Keech, Anthony;
    • Pedersen, Terje R.;
    • Sabatine, Marc S.;
    • Sever, Peter S.;
    • Honarpour, Narimon;
    • Wasserman, Scott M.;
    • Ott, Brian R.
    Publication type:
    Article
    25
    26
    27
    28
    29
    30
    31

    Design and Rationale of the LAPLACE-TIMI 57 Trial: A Phase II, Double-Blind, Placebo-Controlled Study of the Efficacy and Tolerability of a Monoclonal Antibody Inhibitor of PCSK9 in Subjects With Hypercholesterolemia on Background Statin Therapy.

    Published in:
    Clinical Cardiology, 2012, v. 35, n. 7, p. 385, doi. 10.1002/clc.22014
    By:
    • Kohli, Payal;
    • Desai, Nihar R.;
    • Giugliano, Robert P.;
    • Kim, Jae B.;
    • Somaratne, Ransi;
    • Huang, Fannie;
    • Knusel, Beat;
    • McDonald, Shannon;
    • Abrahamsen, Timothy;
    • Wasserman, Scott M.;
    • Scott, Robert;
    • Sabatine, Marc S.
    Publication type:
    Article
    32
    33
    34
    35

    Untitled.

    Published in:
    MD Conference Express, 2009, p. 6
    By:
    • Giugliano, Robert P.;
    • Bonaca, Marc P.
    Publication type:
    Article
    36

    Untitled.

    Published in:
    MD Conference Express, 2009, p. 4
    By:
    • Giugliano, Robert P.;
    • Bonaca, Marc P.
    Publication type:
    Article
    37

    Outcomes of patients with atrial fibrillation and ischemic stroke while on oral anticoagulation.

    Published in:
    European Heart Journal, 2023, v. 44, n. 20, p. 1807, doi. 10.1093/eurheartj/ehad200
    By:
    • Benz, Alexander P;
    • Hohnloser, Stefan H;
    • Eikelboom, John W;
    • Carnicelli, Anthony P;
    • Giugliano, Robert P;
    • Granger, Christopher B;
    • Harrington, Josephine;
    • Hijazi, Ziad;
    • Morrow, David A;
    • Patel, Manesh R;
    • Seiffge, David J;
    • Shoamanesh, Ashkan;
    • Wallentin, Lars;
    • Yi, Qilong;
    • Connolly, Stuart J
    Publication type:
    Article
    38

    Growth differentiation factor 15 and cardiovascular risk: individual patient meta-analysis.

    Published in:
    European Heart Journal, 2023, v. 44, n. 4, p. 293, doi. 10.1093/eurheartj/ehac577
    By:
    • Kato, Eri Toda;
    • Morrow, David A;
    • Guo, Jianping;
    • Berg, David D;
    • Blazing, Michael A;
    • Bohula, Erin A;
    • Bonaca, Marc P;
    • Cannon, Christopher P;
    • Lemos, James A de;
    • Giugliano, Robert P;
    • Jarolim, Petr;
    • Kempf, Tibor;
    • Newby, L Kristin;
    • O'Donoghue, Michelle L;
    • Pfeffer, Marc A;
    • Rifai, Nader;
    • Wiviott, Stephen D;
    • Wollert, Kai C;
    • Braunwald, Eugene;
    • Sabatine, Marc S
    Publication type:
    Article
    39
    40

    A polygenic risk score predicts atrial fibrillation in cardiovascular disease.

    Published in:
    European Heart Journal, 2023, v. 44, n. 3, p. 221, doi. 10.1093/eurheartj/ehac460
    By:
    • Marston, Nicholas A;
    • Garfinkel, Amanda C;
    • Kamanu, Frederick K;
    • Melloni, Giorgio M;
    • Roselli, Carolina;
    • Jarolim, Petr;
    • Berg, David D;
    • Bhatt, Deepak L;
    • Bonaca, Marc P;
    • Cannon, Christopher P;
    • Giugliano, Robert P;
    • O'Donoghue, Michelle L;
    • Raz, Itamar;
    • Scirica, Benjamin M;
    • Braunwald, Eugene;
    • Morrow, David A;
    • Ellinor, Patrick T;
    • Lubitz, Steven A;
    • Sabatine, Marc S;
    • Ruff, Christian T
    Publication type:
    Article
    41
    42
    43
    44
    45
    46

    The facts behind niacin.

    Published in:
    Therapeutic Advances in Cardiovascular Disease, 2011, v. 5, n. 5, p. 227, doi. 10.1177/1753944711419197
    By:
    • Hochholzer, Willibald;
    • Berg, David D.;
    • Giugliano, Robert P.
    Publication type:
    Article
    47

    Lipid lowering goals: back to nature?

    Published in:
    Therapeutic Advances in Cardiovascular Disease, 2010, v. 4, n. 3, p. 185, doi. 10.1177/1753944710368206
    By:
    • Hochholzer, Willibald;
    • Giugliano, Robert P.
    Publication type:
    Article
    48
    49
    50